封面
市場調查報告書
商品編碼
1087047

不孕檢驗的全球市場預測(2022年~2027年)

Fertility Test Market - Forecasts from 2022 to 2027

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 124 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球不孕檢驗的市場規模預測將從2020年的4億9,875萬6,000美元,到2027年達到7億3,961萬6,000美元,在預測期間內預計將以5.79%的年複合成長率成長預測。

本報告提供全球不孕檢驗市場相關調查分析,提供市場概要,市場動態,市場分析,競爭情形,企業簡介等系統性資訊。

目錄

第1章 簡介

  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 前提條件

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 波特的五力分析
    • 供給業者談判力
    • 買方議價能力
    • 新加入廠商業者的威脅
    • 替代品的威脅
    • 產業的競爭企業間的敵對關係
  • 產業價值鏈分析

第5章 不孕檢驗市場分析:各產品

  • 簡介
  • 排卵檢測套組
  • 不孕症螢幕
  • 男性用不孕症檢測套組
  • 其他

第6章 不孕檢驗市場分析:各用途

  • 簡介
  • 女性用不孕症檢驗
  • 男性用不孕症檢驗

第7章 不孕檢驗市場分析:購買模式別

  • 簡介
  • 處方箋
  • 處方箋以外

第8章 不孕檢驗市場分析:各終端用戶

  • 居家醫療
  • 醫院·不孕治療診所

第9章 不孕檢驗市場分析:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 其他
  • 中東·非洲
    • 阿拉伯聯合大公國
    • 南非
    • 以色列
    • 沙烏地阿拉伯
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 台灣
    • 韓國
    • 其他

第10章 競爭環境與分析

  • 主要企業策略分析
  • 新興企業與市場盈利
  • 合併·收購·協定·聯盟
  • 供應商的競爭矩陣

第11章 企業簡介

  • Church & Dwight Co., Inc.
  • Geratherm Medical AG
  • Fertility Focus
  • Fairhaven Health LLC
  • bioZhena Corporation
  • Hilin Life Products, Inc.
  • UEBE Medical GmbH
  • AdvaCare Pharma
  • Mankind Pharma Ltd.
  • Modern Fertility
簡介目錄
Product Code: KSI061611911

The fertility test market is expected to grow at a compound annual growth rate of 5.79% over the forecast period to reach a market size of US$739.616 million in 2027, from US$498.756 million in 2020.

Introduction

Fertility Testing is a process through which males and females are made aware of their reproductive health that helps them to detect ovulation and to diagnose infertility. This procedure aids in planning pregnancy and helps doctors diagnose the cause of infertility as well.

Market Trend

The growing age of the population and the declining fertility rate is expected to be the primary driver for the market. This is because fertility testing can be considered a safe option to detect pregnancy or ovulation and infertility for people trying to get pregnant at high ages. Besides that, the growing prevalence of PCOS and PCOD among females is considered as another major factor to drive up the fertility test market. Today technology is thriving, and the easy-to-use fertility monitors and kits are in wide demand in the fertility test market, thus constituting a vital growth factor for the fertility test market. Also, In the past few years, fertility tourism has surged significantly, holding an opportunity for the fertility test market to grow at a notable rate in the coming years.

Another considerable contribution to this market is the growing self-health awareness among women. Government and authorities at times set up campaigns and awareness programs to provide the required self-health literacy to women in both developed and developing nations. With the increased awareness, the demand for fertility testing is projected to increase in the coming years.

Although the market includes several growth opportunities, one of the major restraints is that these tests, at times, can generate false results that can hamper the market growth in the future.

Growth Factors

  • Declining Birth Rate and Growing Age of First Time Pregnancies:

The decline in fertility rates in the major countries around the globe has become a serious concern. The birth rate of 2.1 is considered as an ideal rate for a country to naturally replace its population. As reported by World Economic Forum, the United States' most recent survey showed that its birth rate has been on a continuous decline for the past six years, and its current rate is at 1.6. The report also showed that the birth rate in China and Japan stands at 1.3 while that in Russia, Brazil, and Bangladesh stands at 1.6, 1.8, and 1.7.

One of the major reasons behind this is the growing age of the population which has simultaneously contributed to the increasing age of first-time pregnancies. According to World Bank, the old-age dependency ratio has increased significantly over the past few decades, and in 2020 it stood at 14.296%. This is expected to be a significant driver of the market as fertility tests can be considered as a safe option to detect the early signs of ovulation and infertility among the high age population.

  • Rising PCOS among the females:

PCOS is one of the major rising causes of infertility among females. PCOS or Polycystic Ovary Syndrome is a hormonal disorder that causes enlarged ovaries and small cysts on the outer edges due to which the ovaries fail to release the eggs, which hampers the menstrual cycle and thereby increases the chances of infertility among women. According to the Centers for Disease Control and Prevention, PCOS affects around 6%-12% (around 5 million) of American women. Since fertility tests can contribute as a primary source of getting information regarding ovulation and infertility, the prevalence of PCOS is directly related to the high demand for fertility tests in the coming years.

  • Fertility Tourism:

Fertility Tourism or cross-border reproductive care or tourism is traveling from one country to another to overcome fertility issues and get fertility treatment. This practice has become popular in the past few decades owing to the factors like strict regulations in domestic countries, better treatment facilities in foreign countries, etc. To work on infertility issues and conceiving problems, fertility tourism involves a high scale application of fertility tests, which can positively impact its market in the forecasted period.

Restraints

  • False Results:

Although the Fertility tests help to get the required information about fertility and ovulation, at times, these tests can detect false results as well. This problem generally arises in the home urine test kits. There can be several causes, like user error, chemical pregnancy, fertility medications, and recent pregnancies, that may leave behind hCG in the bodies. These factors can contribute to the high probability of false result generation, which can hamper market growth.

Impact of COVID-19 Pandemic on the Fertility Test Market:

The outburst of the COVID pandemic around the globe severely hampered the fertility test market majorly because of less access to non-COVID healthcare facilities. The factors like lockdown, curfew, and the fear of disease restricted the outer movement of the people, and this concern increased significantly for the pregnant ladies during the pandemic.

Segmentation:

  • By Product

Ovulation Product Kits

Fertility Monitors

Men Fertility Testing Kits

Others

  • By Application

Female fertility testing

Male fertility testing

  • By Mode of Purchase

Prescription based

Non-prescription based

  • By End-User

Homecare setting

Hospitals and Fertility Clinics

  • By Geography

North America

  • USA
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Others

Europe

  • U.K.
  • Germany
  • France
  • Others

Middle East and Africa

  • UAE
  • South Africa
  • Israel
  • Saudi Arabia
  • Others

Asia-Pacific

  • China
  • Japan
  • India
  • Australia
  • Taiwan
  • South Korea
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. FERTILITY TEST MARKET ANALYSIS, BY PRODUCT

  • 5.1. Introduction
  • 5.2. Ovulation Product Kits
  • 5.3. Fertility Monitors
  • 5.4. Men Fertility Testing Kits
  • 5.5. Others

6. FERTILITY TEST MARKET ANALYSIS, BY APPLICATION

  • 6.1. Introduction
  • 6.2. Female fertility testing
  • 6.3. Male fertility testing

7. FERTILITY TEST MARKET ANALYSIS, BY MODE OF PURCHASE

  • 7.1. Introduction
  • 7.2. Prescription based
  • 7.3. Non-prescription based

8. FERTILITY TEST MARKET ANALYSIS, BY END-USER

  • 8.1. Homecare setting
  • 8.2. Hospitals and Fertility Clinics

9. FERTILITY TEST MARKET ANALYSIS, BY GEOGRAPHY 

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. U.K.
    • 9.4.2. Germany
    • 9.4.3. France
    • 9.4.4. Others
  • 9.5. Middle East and Africa
    • 9.5.1. UAE
    • 9.5.2. South Africa
    • 9.5.3. Israel
    • 9.5.4. Saudi Arabia
    • 9.5.5. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. Japan
    • 9.6.3. India
    • 9.6.4. Australia
    • 9.6.5. Taiwan
    • 9.6.6. South Korea
    • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Emerging Players and Market Lucrativeness
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Vendor Competitiveness Matrix

11. COMPANY PROFILES

  • 11.1. Church & Dwight Co., Inc.
  • 11.2. Geratherm Medical AG
  • 11.3. Fertility Focus 
  • 11.4. Fairhaven Health LLC
  • 11.5. bioZhena Corporation
  • 11.6. Hilin Life Products, Inc.
  • 11.7. UEBE Medical GmbH
  • 11.8. AdvaCare Pharma
  • 11.9. Mankind Pharma Ltd.
  • 11.10. Modern Fertility